BURRELL INTERNATIONAL GROUP LLC

Lobbying for OXYGENIUM INC. · High-flow delivery medical oxygen

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · posted Jul 19, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Funding for portable oxygen generation systems; FY27 Defense Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.